Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?

Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that Sanofi hired Dr. Frank Nestle as global head of immunology & inflammation research therapeutic area and also North America chief scientific officer. Most recently, he was a professor and chair of cutaneous medicine and immunotherapy at King’s College London in the UK.


Pfizer hired Dr. Ole Isacson as chief scientific officer, neuroscience research unit, and senior vice president;

Gilead Sciences hired Rogers Luo as vice president and general manager of commercial operations in China;


Amneal Pharmaceuticals hired Sheldon Hirt as senior vice president and general counsel;

BeiGene hired Dr. Jane Huang as chief medical officer, hematology;

Prothena promoted Gene Kinney to chief operating officer;

Allena Pharmaceuticals hired Edward Wholihan as chief financial officer;

AMAG Pharmaceuticals hired Tony Casciano as senior vice president of sales and marketing;

Concert Pharmaceuticals hired Christine Boisclair as vice president, regulatory affairs;

Concert Pharmaceuticals hired Scott Weintraub as vice president, commercial and product strategy;

GlaxoSmithKline named Andre Vivan da Silva as general manager of its Romanian unit;

ViiV Healthcare named Barbara Cygler as deputy manager for France and Belgium;

CureSeq hired Brett Robertson as chief executive officer;

Novasep hired Francois D’Hooge as bioconjugation unit manager;

Galmed Pharmaceuticals hired Liat Hayardeny as chief scientific officer;

Orbsen Therapeutics hired Larry Couture as chief executive officer;

Decibel Therapeutics hired Michael Su as chief scientific officer;

Decibel Therapeutics hired Paula Cobb as senior vice president of strategy, portfolio, and programs;

Decibel Therapeutics hired John Lee as senior vice president of pharmaceutical development;

Decibel Therapeutics hired Pete Castrichini as vice president of human resources;

CEL-SCI says its president Maximilian de Clara resigned for health reasons;

Progenics Pharmaceuticals hired Bryce Tenbarge as vice president, commercial;

Redx Pharma says chief financial officer Phil Tottey is leaving;

Redx Pharma hired Karl Hard as head of investor relations and corporate communications.